(FWHM) = 5 to 10 mm resolution range between -0.9 and -6% in dynamic CBF measurements with intrave nous (i. v.) bolus injection of 150-water or inhalation of 18F-fluoromethane and total measurement times of6 or 10 min, respectively. Binding or metabolic rates determined with tracers that are essentially trapped in tissue (e.g., FDG for measurement of cerebral glucose metabolism) are only slightly overestimated (0.5-3.0%) at typical measurement times and are essentially independent of the shape of the input function. The error increases con siderably if tracer accumulation is very slow, however, or if short measurement times [<5/(k2 + k3)] are used. Some rate constants are also subject to larger errors. Key Words: Heterogeneity-Compartmental models-Non linear regression-Dynamic PET -Cerebral blood flow -Cerebral metabolism. sured mean tracer activity will not yield the precise mean values of the physiologic parameters in that tissue if the model equation involves nonlinear terms.
In the present article, a method of calculating es timates of the difference between the true mean pa rameter values and those obtained by nonlinear curve fitting is described. It generalizes, for dy namic measurements, an approach described by Bass and Robinson (1982) and is based on Ta ylor expansions of the equations for the measured tissue activity and the fitted curve.
The proposed method was applied to compart mental models currently used in positron emission tomography (PET) . Although these models assume that all processes follow first-order kinetics and the basic differential equations are linear, the equations describing total tracer activity often involve expo nential, i.e., nonlinear, terms. A model involving one tissue compartment has been applied to mea surement of CBF using 77Kr (Yamamoto et aI., 1977) and 18F-fluoromethane (Holden et aI., 1981) using a least-squares fit. Essentially the same model was also used for CBF measurements using 150-water (Huang et aI., 1983; Raichle et aI., 1983; Alpert et aI., 1984) or inhalation of 150-carbon dioxide (Kanno et aI., 1984) , but the model equa tions were integrated for computation of regional CBF instead of curve fitting. The same model has been used elsewhere for quantification of blood brain-barrier (BBB) permeability (Hawkins et aI., 1984) . Adding another compartment permits mea surement of cerebral glucose metabolism with 18F-2-fluor-2-deoxyglucose (Phelps et aI., 1979b; Huang et aI., 1980; Heiss et aI., 1984) or ll C-2-de oxyglucose (Reivich et aI., 1982) . A mathematically equivalent compartmental model has also been used for quantification of dopamine and serotonin binding capacity with IIC-methyl-spiperone (Wong et aI., 1984) and estimation of cerebral protein me tabolism using ll C-methionine (Bustany et aI., 1983) . Because of the complexity of protein metab olism, models involving even more compartments have been designed (Phelps et aI., 1984) . They are, however, not yet in common use, and are therefore not included in the examples in this article.
Tissue heterogeneity, as seen in PET, results from at least three different sources. In currently available PET scanners, each pixel of a tomo graphic image comprises contributions from � 1 cm 3 tissue volume, depending on the resolution of the device. Although technical progress will prob ably reduce this volume further, the highly 'com plicated shape and the close proximity of brain structures with grossly different blood flow and me tabolism inevitably cause some sort of "phys icoanatomical" heterogeneity. The second source of apparent heterogeneity is related to the defini tion of regions of interest. Frequently, tracer ac tivity is measured within regions of rigid geometric shapes (e.g., circles or rectangles) that do not match the shape of brain structures and therefore include arbitrarily large amounts of both gray and white matter. The contributions from this source can be minimized by performing the fits on a pixel by-pixel basis, which is practically feasible with ap propriate computer equipment and speed-opti mized fitting routines (Holden et aI., 1981) , or using regions of interest that are as homogenous as pos sible and that can be generated by a semiautomatic mapping procedure (Herholz et aI., 1985) . The third source is the tissue heterogeneity on a microscop ical level (e.g., variability of capillary perfusion, columnar organization of functional cortical units, pathological tissue as in brain tumors and infarcts), which may be regarded not only as a source of error, but also as an interesting biological phenom enon.
GENERAL METHOD
The concentration of a tracer in tissue is a function of time t and of the parameters, Pi (i from 0 to n), involved in the particular model. Using vector notation, P = (Po, . .. , P o ), this function, which may be called the opera tional function of the model, can be written as C(p, t). In a strict sense, however, it applies only to homogeneous tissue parts. In actual measurements, the tissue will show some heterogeneity with respect to the parameters. Thus, the accumulated tracer activity, M, (per tissue volume or mass) can be regarded as the mean of tissue activities in each of the Q, tiny homogenous tissue parts of equal volume or mass:
with M(t) measured activity in heterogenous tissue at time t, and p(q) parameter vector of the q-th tissue part. The p(q) are distributed around a mean value, 15, which is given by
The measured activity will be expressed in terms of the mean parameters and their variation. Thus, using a Ta ylor expansion and neglecting terms of third or higher order yields
Q q �l i�O a pi 1 Q 0 0 1 a2c
Q q �li�O j� o2 ap i ap j
The first term in this equation depends only on the mean parameters p. The second term disappears since the Pi are the means of the pfq) according to eq. 2. The third term includes the variances and covariances of the pa rameters 1 Q a7. = _. "" (P (q) -15,) . (P (q) -15,)
in connection with the second partial derivatives of the operational function. For linear models, all second and higher derivatives equal zero, but for nonlinear models at least some of them will contribute to the measured ac tivity. Thus, the measured activity can be estimated by 1 0 0 a2c M(t) = C(p,t) + -2: 2: --(p,t) . au· (5) 2 i�O j�O ap i ap j
In an actual measurement, a curve, Cfit ( p , t) is fitted to the measured data, where Cfit has, of course, the same functional form as C. Due to tissue heterogeneity, the fitted parameter vector P will, in nonlinear models, gen erally not be equal to the true mean p. Their difference appears in a Ta ylor expansion of the fitted curve, where terms of second or higher order are neglected because we will consider only small differences:
For calculation of the sum of squares, S, in a least squares fit, the actual times of measurement tl (1 from 1 to r, where r is the number of measurements) are to be known, and a weighting function w e t) may be used to ac count for unequal accuracy at the various measurement times:
To illustrate some specific examples, it will be useful to approximate the summation by an integral over the total measurement time T. Thus,
S is minimal if its partial derivatives with respect to all P k (k from 0 to n) are zero. Because only Cfit depends lin early on p , the derivatives are easily obtained and yield, using scalar product notation to represent both discrete and continuous time measurements:
Since equation (8) must be satisfied for each k (from 0 to n), a system of linear equation is obtained from which the errors, t:.P i = P i -Pi , or in vector notation t:.p = Pp,
i.e., the differences between the fitted and the true mean parameters, can be determined, provided that the opera tional function C(p , t) is given. The errors, which are functions of the parameter variances and covariances, also depend on the shape of the input function, the actual measurement times, and the estimates of the true mean parameters for which the partial derivatives are calcu lated. The equation system can be conveniently written, using matrix notation as: 
To find the effects of the various variances and covari ances, it will be convenient to split b k into components, W ) , with respect to the (Tij .
Due to the symmetry of the derivatives and (co)vari ances with respect to i and j, only the cases where i "" j need to be considered. Thus, defining b�j) as:
The resultant errors may also be split into the contribu tions of the various variances and covariances. Hence, if t:.p(ij) is the solution of
where b@ represents the column vector of the b�j), and both sides of eq. 9d are multiplied by (Tij and summed over all ij (j � i), then inserting eq. 9a and 9c yields: n n t:.p = 2: 2: t:.p(ij) . (TG'
i=O j=i
Derivation of some rules
(ge)
A nonlinear model equation will usually include linear as well as nonlinear parameters. For any linear parameter which, without loss of generality, will subsequently be denoted by the index 0, the operational function can be written as:
where F and G are functions of subsets p(F) and p(G) of the other parameters, which may be linear or nonlinear. These subsets may or may not overlap, and both together with Po establish the original set of parameters (Po , ... , P n ) · The partial derivatives with respect to Po are then:
aFlapi is nonzero only if Pi is included in the parameter subset p(F) , i.e.,
The second partial derivatives with respect to the other parameters (i "'" 0 and j "'" 0) are: (lIe) a2Flapiapj and a2Glapiapj are nonzero only if both param eters P i and Pj occur together in at least one of the subsets p(F) and p(G). Therefore, a2Clapiapj ¥ 0 only if P i E p(F) and Pj E p(F) (lIt) or P i E p(G) and Pj E p(G)
If i = j, at least one of both conditions is obviously ful filled.
Because the (co)variances are multiplied with the cor responding second partial derivatives (eq. 9b), only those (co)variances contribute to the resulting errors !:J.p which are coupled to nonzero second partial derivatives. Thus, the following rules are obtained.
Rule 1. Variances of linear parameters do not con tribute to heterogeneity errors (eq. II b).
Rule 2. Covariances between parameters contribute to heterogeneity errors only if the operational function cannot be separated into a sum of two functions, each of which is dependent on only one of these two parameters (eqs. lld and llt).
In general, the values of the derivatives of F(P(F),t) and G(p(G) ,f) at the mean parameter-vector value P depend on the mean values of those parameters which occur in the functions. The mean value of a linear parameter, how ever, only occurs if this parameter is multiplied by a function of at least one other parameter (eq. lIe); i.e., p(F) must comprise at least one P i ' Otherwise, Po will not occur in the equation system (eq. 9a), since then F(P(F),t)
= F(f) and thus aClapi = aGlapi for i ¥ 0 and aC/apo = F(f), neither partial being a function of Po. The same re sult is obviously true for the second partials. Therefore an additional rule emerges.
Rule 3. The magnitude of heterogeneity errors (of any parameter) does not depend on mean value estimates of those linear parameters which are not multiplied by a function of at least one other parameter.
If the second partial is zero, higher partials will also be zero. Thus, all three rules are still valid if higher order terms in the Ta ylor expansion of measured activity (eq. 3) are not neglected. They can therefore also be applied to cases of large tissue heterogeneities. If there is a second linear parameter present which is a factor only of func tion F of equation 10, the product of the two linear pa rameters may be treated as a linear parameter in its own right and the values of the separate linear parameters cannot be separately evaluated. Thus, only the situation in which all other linear parameters besides Po are not solely factors of function F of eq. 10 need be considered.
Under certain circumstances, the effect of the covari ances between linear and nonlinear variables (J�i' Pi non linear) can be further specified. Considering the corre sponding bro i l with P i E p(F), eq. 9b yields:
ap O api ap k
By virtue of eq. IIc, it follows that:
.
api ap k
The aik are Ceq. 9a):
If P i is not an element of the subset p(G), i.e., it occurs only in the function F(P(F),f) which multiplies the linear parameter Po but not in function G(p(G) ,f), then aClapi = Po . aFlapi, and consequently
Because both scalar products in aik and bkO i ) are equal under this condition, one obtains if P i E p(F) and P i f1 p(G). ( 16)
The equation system (eq. 9d) can now be solved using Cremer's rule:
where matrix A� i ) is the same as A, except that all akm'
i.e., all elements of the m-th column, are replaced by the bk°i).
Now, by virtue of eq. 16 and the fact that the deter minant is 0 if any two columns of the determinant are multiples of each other, it follows that
This equation can be expressed in words as an additional rule which, in contrast to the previous rules, depends on the assumption that tissue heterogeneity is small enough not to invalidate the neglecting of higher order terms in eqs. 3 and 6.
Rule 4. The covariance between a linear and a non linear parameter occurring only in the function multi plying the linear parameter, but not elsewhere, affects only the heterogeneity error of the nonlinear parameter, but not the errors of any other parameter. The effect de pends only on the covariance and the respective mean parameter values but not on the particular input function or measurement protocol.
APPLICATION TO SOME COMPARTMENTAL MODELS
A catenary three-compartmental model ( Fig. 1 ) can be quantitatively described by the intravascular tracer distribution volume P o (milliliter per gram of brain tissue) and 4 rate constants: k l (ml/g tissue/ min) describes transport of diffusion from blood to tissue, k 2 (min-I) describes the reverse process. Binding or metabolism of the tracer, if occurring, is described by k3 (min-I), and the reverse process is described by k4 (min -I). Assuming that all these processes obey first-order kinetics and all compart ments are well mixed, the law of conservation of mass leads to a set of differential equations which yield by integration the operational function de- scribing total tracer activity (modified from Huang et aI., 1980) :
where Ca(t) is the input function, i.e. , the tracer ac tivity in arterial blood, and the parameters PI to P4 are related to the rate constants kl-k4 by the fol lowing equations:
It will be convenient to choose Po, ... , P4 initially as the parameters to be analyzed. If, in a particular application, not all of the compartments or pro cesses are actually involved, the above equations can be reduced to simpler ones as follows.
Model O. The tracer does not cross the BBB (e. g. , erythrocytes labeled with ll C _ or 150-carbon monoxide); thus, only the blood volume is mea sured.
Modell. The tracer crosses the BBB but is com pletely trapped in tissue (e. g., highly lipophilic sub stances), or measurement times are short enough to neglect backtransport. This model is frequently used to measure rates of uptake into tissues (Ohno et aI., 1978) . 1987 Model 2. The tracer crosses the BBB in both di rections, and there is only one tissue compartment, i. e., extra-and intracellular space can be treated as one compartment, and there is no binding or metab olism of the tracer.
with PI = kl and P 2 = k 2· This model is frequently used for CBF measure ment with freely diffusible tracers, where kl (and thus PI) equals blood flow, and the ratio, A = k/k 2 ( = PI/P 2 )' represents the equilibrium tissue/blood distribution coefficient of the tracer.
Model 3. The tracer is bound or metabolized, but the reverse process does not occur or is negligible during measurement time.
P 2 is the turnover rate of the second compartment, whereas P3 represents the amount of tracer (relative to its intravascular activity) that is metabolized or bound per time unit. In deoxyglucose studies it is multiplied by the plasma glucose concentration and divided by the lumped constant to yield the meta bolic rate of glucose (Phelps et aI., 1979b) . Model 4. All processes must be considered; the original equation (eq. 19) applies. The binding or metabolic rate in this model is
Heterogeneity effects in these compartmental models can be specified by application of the rules developed in the previous section. Because Po, PI' and P3 are linear parameters, their variances do not contribute (rule 1); thus, only the variances (T�2 and (T�4 need be considered. Furthermore, all param eters besides PI and PZ' and P3 and P4' respectively, occur in separate additive terms of the operational function; therefore, according to rule 2, only the co variances (TIz and (T�4 contribute to heterogeneity errors. As a trivial consequence, model 0 and 1 which involve only the linear parameters Po and PI are not affected by heterogeneity errors and need no further consideration.
For the remaining models, the effects can be fur-ther specified. Because both contributing covari ances involve one linear (P I and P3 respectively) and one nonlinear variable (P 2 and P4 respectively), they affect only the errors of P 2 and P4' respec tively. This effect can be quantified, without further calculation, according to rule 4 and eq. 18. Rule 3 indicates that the errors do not depend on the mean parameter estimate P o . Furthermore, for model 3, rule 3 indicates that the errors do not depend on the mean parameter estimate 153' Thus, using the nota tion of eq. ge, the solution of equation system 9 can be written as:
6. Po 6. PI 6. P 2 6. P3 6. P4 (21) where the t::. . pf 22 ) and t::. . p( 44 ) (i from 0 to 4) are still to be determined as functions of PI to 154' the input function, and the measurement time frame. In models 2 and 3, where k4 = P4 = 0, the solution is further simplified, since all terms involving U j4 and U �4 disappear and, from Rule 3, the 6.pF 2 ) (i from 0
to 3) are functions of only P I and 15 2 '
If the extravasation rate of a tracer is relatively high as compared with the time required to collect sufficient counts for one scan of a dynamic PET series, it is not possible to obtain a reasonably ac curate estimate of the intravascular tracer distribu tion volume Po. Under these circumstances, which are inevitable in CBF measurements with freely diffusible tracers, it is desirable to obtain a indepen dent measurement for blood volume (Phelps et aI., 1979a) to get an estimate of Po and to subtract that from the measured activity. If such a measurement is not available, the relatively small intravascular volume Po is frequently neglected. Heterogeneity effects were therefore also calculated for this par ticular situation.
Because of eq. 21, actual calculation of the pa rameters of the equation system 9 only requires the following partial derivatives of the operational function (eq. 19): aC -(/5,t) ap 2 ac -(/5,t) ap3 ac -(/5,t) ap4 a 2 c -(/5,t) ap�
Models 2 and 3 with k4 = P4 = 0 will be consid ered initially. Hence, all partial derivatives with re spect to P4 are irrelevant and the partial derivative with respect to P3 becomes:
Thus, all the above equations may be written such that the measurement times occur only in a product with P 2 ' provided that the input function is also de scribed relative to 15 2 as Ca'(/5 2 t) = Ca(t).
Because the time-independent mean parameter estimates can be written in front of the scalar products for calculation of the coefficients of equa tion system 9, e.g. ,
the time-independent part of its solution can be cal culated without any assumptions about actual mea surement data. Therefore, if eq. 22a and 22b are in serted into eq. 9a-ge and rearranged, it may be easily seen that eq. 21 becomes t::. . P o = CP / P 2 ) • EOCP 2 . T) . V � 2 t::. . PI = P I . EI(/5 2 . T) . V � 2 t::. . P 2 = 15 2 • E 2 (/5 2 . T) . V � 2 + 15 2 • v I 2 t::. . P3 = P I . E3(/5 2 . T) . V � 2 '
where v * = u*/p -.• p -. and the time-dependent func-IJ IJ I J tions EO(P 2 T) to E3(P 2 T) involve only the mean estimate P 2 as a factor for time scaling. The Ej(P 2 T), i from 0 to 3, depend on the particular input function and, in the discrete case, depend also on the actual measurement time frame (both relative to /5 2 )'
Interestingly, the relative errors of P I and P2 can be written as:
whereas those of P o and P 3 are not dependent on the corresponding mean estimates, as mentioned ear lier.
The e-functions were calculated numerically using appropriate computer programs for monoex ponentially decaying input functions C a (t) = C: . e -l3t (C: being an arbitrary scaling constant which cancels out in the equation system), and the ex treme cases of a Dirac-I) (� ....,. (0) and a constant (� = 0) input function. For model 2 (blood flow or permeability measurement), a linearly increasing input function, C a (t) = C: . �t, and functions that approach exponentially a constant value, C a (t) = C: . (1e -13t), were also used. For simplicity, the integral definition of the scalar product (eq. 7b) was assumed. Furthermore, a perfect measurement without noise was assumed, so that the weighting function was assumed to be constant. The e-func tions were also calculated numerically for some plasma input functions and P2 values actually ob served in typical patient studies that used standard measurement time frames and the discrete defini tion of the scalar product (eq. 7a).
For model 4 (nonzero k4 and P4), a similarly con venient separation of the time-dependent part could not be achieved, and the larger number of (co)-vari ances involved restricted the analyses to an input function and mean parameter values obtained in typical FDG studies.
To ascertain the actual magnitude of errors in practical situations, the variance due to heteroge neity with PET arising from its limited resolution was estimated for typical CBF and glucose metabo lism measurements. It has been shown by autoradi ography that ratios of gray matter to white matter of blood flow and glucose metabolism �4: 1 (Ken nedy et aI., 1978) . In an actual PET measurement, due to the limited resolution of the machine relative to the actual size of the regions of gray or white matter, signals from pure gray matter or pure white matter regions cannot be obtained. Thus, in an ap parent gray matter region there will be some white matter present and vice-versa, so that the apparent ratio of gray matter to white matter of blood flow or glucose metabolism, Ra pp ' will be <4.
Let Papp , g r a y and Papp ,white be the apparent values of the parameter in the apparent gray and white matter and Pa ct, g r a y and Pact, white be the actual values of the parameter in the actual gray and white matter. If x is the fraction of actual gray matter in J Cereb Blood Flow Me t ab, Vol. 7, No.2, 1987 the apparent white matter region, and if we assume for simplicity that x is also the fraction of actual white matter in the apparent gray matter region, then Papp,gray = (1 -x ) . Pact,gray + X • Pact,white (25) Papp,white = X • Pact,gray + (1 -x) . Pact,white'
Since Papp,gray = R a pp . Papp,white and Pact,gray = 4 . Pact,white' eq. 25 may be solved to yield
Let a 2 be the variance of the single parameter Pap ,gray as in eq. 4. Then v 2 , which is equal to a 2 J��pp ,gray for the parameter within the apparent gray matter region adjusted for the presence of the white matter, is determined by the relative contri butions of the gray and white matter. Assuming that the actual gray and white matter are homogeneous, 
Substituting eq. 26 into eq. 27a yields, after elementary rearrangement, v 2 = (4, R a pp -1)(4 -R a pp)J(25 . R�pp). (27b) Mazziotta et ai. (1981) calculated average ap parent ratios of gray to white matter, R a pp' in simu lation studies based on human brain anatomy as a function of the resolution of the scanner. Ratios for typical resolution values given as full width at half maximum (FWHM), and the resulting variances due to heterogeneity, as determined from eq. 27b, are listed in Ta ble 1. Because the resolution of many currently used scanners is between 5 and 10 mm FWHM, a value of v 2 = 0.1 was used throughout the presentation of the results as a guideline for estimation of typical "physicoana tomical" heterogeneity effects.
RESULTS
The results of the application to compartmental models are mainly described in terms of the e-func- tions. These E-functions represent the part of the error that depends on measurement time and the shape of the input function. They are plotted in Figs. 3-9 , and the E-values for specific measure ment times and input functions can be obtained from these plots. To obtain the actual errors of the parameters, the E-values must be multiplied by the respective variances and covariances describing tissue heterogeneity quantitatively and by the re spective mean parameter values as specified in eq. 24a. The meaning of the parameters P o to P 3 de pends on the particular model under consideration; this was described in eqs. 20a-20d. Generally, the E-functions for the monoexpo nentially decaying input functions lie between those for the extremes of the Dirac-5 bolus injection and the constant input function. The errors determined on the basis of increasing input functions (model 2 only) were close to those of constant input, and input functions observed in actual measurements gave results closely comparable to those of mono- exponentially decaying functions. Thus, the mono exponentially decaying functions actually yielded an error range that was also representative for all other tested situations. 
Then, inserting eq. 24b into eq. 28a yields fl A/}:. = (E tC"P2 1) -E2(P2 1) ) . V�2 -v t2' (28b) Accordingly, (E I -E 2 ) is shown in Fig. 5 . CBF or permeability, measured as kl = P I (Fig.  3) is generally underestimated in heterogenous tissue, and the underestimation increases with mea- surement time. The smallest error is obtained for a B-input function, raidly approaching a constant value of EI = -0. 25 (Fig. 3a, curve A) . Relatively large errors are obtained for constant input (fig. 3a , curve E) or increasing input functions (Fig. 3b) . The two curves shown were selected from a variety of curves which were very close to each other and had values of 13 between 0. 1 and 10.0. The errors for practically observed input functions after intra venous (i. v.) bolus injection of 150-water ( Figs. 2a  and 3c , � = 0. 9 mllg) or 2. 5 min inhalation of 18F_ fluoromethane in a closed system ( Figs. 2b and 3d , � = 1 mllg) compare well with the error range for the "idealized" input functions. Because of the fixed input functions (not defined relative to P2 as in Figs. 3a and b ), different curves (H, K, and L) were obtained for each flow level and the corresponding P2 = k 2 = k l/� ' The errors of P2 ( Fig. 4) and A (Fig. 5 ) depend also on the constant contribution of vI2 (eqs. 24a and 28b). At least for freely diffusible substances used for CBF measurements, it seems reasonable that there is a close correlation between k\ and k2' since the variability of the partition coefficient A is usually small. Therefore, vh should be approxi mately equal to V�2' and the relative errors become
Thus, after adding 1 to the ordinate value (E2), Fig.  4 indicates that there is an overestimation of P2 which approaches zero for longer measurement times and rapidly decaying input functions (A and B), whereas for slowly decaying (C and D), in creasing (F and G), or constant (E) input functions initial over-estimation becomes underestimation for longer measurement times. Similarly, if 1 is sub tracted from the plot of (E\ -E2), Fig. 5 indicates that there is some underestimation of A which de creases for longer measurement time, approaching zero for constant (E) and increasing (F and G) input. As for PI' the errors of P2 and A obtained for the two examples of actual measurements (Figs. 4c  and d and 5c and d) are similar to those obtained with the idealized input curves (Figs. 4a and b and  5a and b) , and the errors for increasing input (F and G) are similar to those for constant input (E).
Assuming that the variance of the partition coef ficient is negligible, it follows that the relative vari ances and covariances of all parameters are equal. As discussed in the Methods section, the variance due to typical physicoanatomical heterogeneity would be approximately equal to 0. 1; thus, this value is used for VII = vI2 = V�2 in the following estimations. For a mean gray matter blood flow of 0.7 mllg/ min and a total measurement time T of 10 min is /52 • T = 7; thus, taking the range of EI and E2 from Figs. 3a and 4a and inserting it into eq. 24b, the relative error of CBF (dp/PI) would range between -2.5 and -6%, that of P2 between _ O and -5%, and that of X. (Fig. 5a , eq. 28b with X. = 1) between -0.9 and -2.5%. In conclusion, usage of rapidly decaying, input functions (bolus techniques or short inhalation), and short measurement times minimizes the underestimation of CBF or perme-ability, whereas constant or increasing input func tions cause larger errors in this variable but mini mize the error in the estimation of the partition co efficient.
Model 3: Tracer binding or metabolism. Errors in parameters PI to P3 (eq. 20d), (Figs. 6-8) were calculated for fits with and without Po. The errors in Po itself are shown in Fig. 9 . The results for fits without Po are shown in the a sections of Figs. 6-8; the comparison between both approaches are shown in the b sections. It demonstrates that the E-functions for the rapidly decaying input functions, and including Po into the fit, approach that for the Dirac-o input function without fit of Po. The inclu sion of Po into the fit causes a somewhat larger un- 1987 derestimation of PI and P2' mainly for slowly de caying or constant input functions ( Figs. 6b and 7b , curves C-E), whereas it only minimally affects the resulting errors of P3 (Fig. 8b) . Numerical error cal culations for typical FDG rate constants, a typical discrete measurement time grid (Heiss et aI., 1984) , and a typical multiexponentially decaying input function (Hawkins et aI., 1981) without fit of plasma volume are shown in the C sections of Figs. 6-8 (curves M and N); they are very close to those of rapidly decaying monoexponential input func tions. The intravascular distribution volume Po, if fitted, is overestimated due to heterogeneity (Fig.  9) ; the overestimation increases with measurement time and is more severe for slowly than for rapidly decaying input functions. The magnitude of the error also depends on the actual ratio PI/P2 (eq. 24a), and on its relation to Po. With typical gray matter transfer constants, (k1 = 0.0886, k2 = 0.1 371, k3 = 0.0685, Heiss et al., 1984) , mean cere bral plasma volume Po = 0. 03 mllg, and V�2 = 0.1, the percentage overestimation relative to Po ranges between 1.9% for a rapidly decaying input function ( [3 /P2 = 10) and 12.2% for constant input at a total measurement time of 50 min. The E-functions, and in model 2. In most applications of model 3, both parameters are, however, only of minor interest. Parameter P3' representing the total binding or metabolic rate, is over-estimated in heterogenous tissue (Fig. 8) . Remarkably, the error decreases rapidly and approaches zero as measurement time increases, and there is only a minimal dependence on the shape of the input function. Using the same mean gray matter parameter estimates as above, the error of P3 relative to its mean estimate is only 0.5-0.8% at 50 min total measurement time. This relative error may be considerably larger, however, if P3 is very small as compared to PI' since tlp3 de pends on PI but not on P3 (eq. 24a). Thus, even when the tracer is not bound or metabolized ([53 = 0), an attempt to fit P3 in heterogenous tissue could yield a value significantly different from zero, espe cially if measurement times were relatively short. Thus, conclusions about presence or absence of metabolism or binding of a tracer must be drawn with some caution.
Model 4: Reversible metabolism or binding. Be cause a convenient separation of the time-depen dent part could not be achieved in this case, the analysis was limited to a typical FDG plasma curve and rate constants for gray and white matter and severely ischemic tissue (Hawkins et aI., 1981) . A typical discrete-measurement time grid was used and the plasma volume Po was fitted. Several com binations of variances and covariances of the rate constants (aB(k) in absolute, vG(k) in relative terms, where the index (k) indicates that they correspond to the rate constants kl to k4 rather than to PI to P4) were considered, and were transformed into the corresponding (co)variances of the parameters PI to P4 by the approximate first-order transformation equations: Vol. 7, No.2, 1987 To find the extremes of possible errors, it was first assumed that all variances and covariances are equal (i.e., all processes vary to the same extent and are perfectly coupled), or second, that all vari ances are equal, but covariances are zero (i.e., all processes vary to the same extent but are com pletely independent). Either perfect coupling and complete independence of rate constants is unlikely to occur under physiological conditions. These were intended to be represented by two other com binations: (third) all variances are equal and covari ances are half the value of corresponding variances (i.e" all processes vary to the same extent and are coupled by a correlation coefficient of �0.7); and fourth, variances of k3 and k4 are half of those of kl and k2 and covariances are half the value of corre sponding variances (i.e" the metabolic processes vary less than the blood flow and transport-related processes, and all processes are coupled by a cor relation coefficient of � o . 7).
All combinations were equally scaled to yield a relative variance of the metabolic rate, VK.,. R ' of 0. 1, according to earlier considerations. The errors tlpo to !J.P4 determined under these assumptions were approximately transformed into errors of the meta bolic rate and of the four rate constants using again first-order conversion equations: n ak tlkj = 2: _I • tlP j . exception of Po, all errors tended to be larger for lower metabolic rates. Generally, there was a ten dency toward negative errors if covariances were assumed to be low and toward positive errors if co variances were high because of the constant effect of covariances on !1P2 and !1P4 (eq. 21). As in model 3, the errors of the metabolic rate were generally very small, whereas the magnitude of errors in the rate constants increased from kl to k4•
DISCUSSION
Models used for quantitation of physiologic pro cesses are necessarily approximations of the actual, usually very complicated situation. The analysis of tissue heterogeneity can therefore be viewed in this context as an attempt to account for one special aspect of the incompleteness of such models. In the present approach, it is assumed that the various tissue parts contributing to heterogeneity can be considered parallel to each other with respect to tracer supply, and that they do not exchange tracer, e.g., by diffusion. This appears to be a reasonable assumption for compartmental models designed for the description of a single capillary and the tissue supplied by it without tracer exchange between these capillary units. It is also appropriate in the analysis of resolution and region of interest size-de pendent heterogeneity.
The parallel action of units with different, but constant physiologic parameters is, however, not the only possible source of biological heteroge neity. There may be processes with changing pa rameters during measurement time in each of the units under consideration. Such a situation is indi cated by reports describing observations of micro circulation in which corpuscular blood elements entered capillaries in a highly variable stochastic manner (Fung, 1973) . Changes that are very quick relative to the time constants involved in the model and are occurring similarly in all units probably would be covered by the present approach, whereas slow time-dependent changes clearly would not be. Further research is certainly re quired, however, to answer this question. If the capillary units are not acting parallel but are serially connected, or form a complex network, a different kind of heterogeneity emerges ("heterogeneity of the second kind", Bass and Robinson, 1982) . A similar problem, as far as compartmental models are regarded, is related to the assumption that the compartments are well mixed. For freely diffusible tracers used for blood flow measurements, this as sumption is clearly inaccurate because of the in constancy of the plasma tracer concentration as it passes the capillary; for less diffusible tracers, non instantaneous diffusion within tissue compartments may cause inaccuracies. This "heterogeneity within compartments" cannot be handled by the presented method. Distributed models which ac count for this type of problem have been developed for some tracers (Bassingthwaighte, 1974) , but their application to PET is as yet barred by their mathe matical complexity and the large number of vari ables involved. Further methodological progress could, however, reduce the number of unknown variables, and such models could be used for curve fitting. The present analysis of "parallel" heteroge neity could then also be applied to these distributed models that account for "serial" heterogeneity within the parallel units.
Previous studies of heterogeneity effects in PET measurements were performed by simulation of particular situations in particular models. A study on heterogeneity effects in steady-state CBF mea surements during inhalation of [ 150]carbon dioxide (Herscovitch and Raichle, 1983) showed that with this particular method considerable underestima tion of CBF occurs in heterogenous tissue, whereas the autoradiographic method (Raichle et a!., 1983), which uses only the activity integrated over the first 40 s after i. v. injection of a [150]water bolus, is less affected by heterogeneity errors. Although nei ther method uses curve fitting to dynamic data, the findings correspond to the high CBF underestima tion that is determined for constant input at long measurement times and the much smaller errors if total measurement time is short (Figs. 3a and 4a ). Accordingly, Carson et ai . (1986) determined mod erate heterogeneity effects for a dynamic CBF mea surement using i. v. [ 1 50]water injection and weighted integrations instead of curve fitting over a total measurement time of �6 min.
The present results showed that the magnitude of heterogeneity errors of most clinically interesting parameters, such as CBF, glucose metabolism, and tracer binding can be expected to be usually <10%, frequently even � 1 %. Therefore, they do not ex ceed the range of other typical errors of PET mea surements as caused by inaccurate attenuation cor rection (Huang et aI ., 1979) , partial volume effects (Mazziotta et aI., 1981 ) , or timing errors (Patlak et aI ., 1984) . Because they are systematic, they must nevertheless be regarded as a significant source of error, particularly if the values obtained from dif ferent measurements using different models are combined to values expected to exhibit relatively small physiological variance, e.g., ratios of regional glucose and oxygen metabolism. Although other errors, e.g., due to inaccurate attenuation correc-tion or linear partial volume effects, would tend to cancel out in such ratios, heterogeneity errors might not.
It is remarkable that not only the nonlinear, but also the linear parameters are affected by heteroge neity errors as soon as there is one nonlinear pa rameter in the model. Although the error of the linear parameter Po can be even larger than that of . the nonlinear parameter P2, the clinically most in teresting parameter P3 or PMR respectively (meta bolic or binding rate) is relatively stable, further supporting the robustness of cerebral glucose mea surement using deoxyglucose (Sokoloff et al. , 1977) . This appears to be related to the fact that the convolution integral involving P2 approaches a con stant value as soon as changes in plasma activity are relatively small when compared with the amount of activity already present in tissue. In this kind of steady-state situation, the tracer uptake curve relative to plasma activity approaches a straight line with slope P3 (Patlak et aI., 1983) ; i. e. , the whole model is asymptotically linear. As shown for model 4, this stability is not essentially changed if a small k4 is present and included in the fit using measurement times of �90 min.
